Two	CD	OTHER	O 0 3	[1]	[3]	CAPITALIZED	allAlpha
methods	NNS	NP	O 4 11	[2]	[7]	LOWERCASE	allAlpha
of	IN	OTHER	O 12 14	[3]	[2]	LOWERCASE	allAlpha
formulating	VBG	VP	B-KP 15 26	[4]	[11]	LOWERCASE	allAlpha
anionic	JJ	NP	I-KP 27 34	[5]	[7]	LOWERCASE	allAlpha
nanocomplexes	NNS	NP	I-KP 35 48	[6]	[13]	LOWERCASE	allAlpha
were	VBD	VP	O 49 53	[7]	[4]	LOWERCASE	allAlpha
evaluated.	NN	NP	O 54 63	[8]	[10]	LOWERCASE	ContainSymbol

In	IN	PP	O 65 67	[1]	[2]	CAPITALIZED	allAlpha
both,	NN	NP	O 68 72	[2]	[5]	LOWERCASE	ContainSymbol
nanocomplexes	NNS	NP	B-KP 74 87	[3]	[13]	LOWERCASE	allAlpha
were	VBD	VP	O 88 92	[4]	[4]	LOWERCASE	allAlpha
prepared	VBN	VP	B-KP 93 101	[5]	[8]	LOWERCASE	allAlpha
in	IN	PP	O 102 104	[6]	[2]	LOWERCASE	allAlpha
water	NN	NP	O 105 110	[7]	[5]	LOWERCASE	allAlpha
at	IN	OTHER	O 111 113	[8]	[2]	LOWERCASE	allAlpha
a	DT	OTHER	O 114 115	[9]	[1]	LOWERCASE	allAlpha
range	NN	NP	O 116 121	[10]	[5]	LOWERCASE	allAlpha
of	IN	PP	O 122 124	[11]	[2]	LOWERCASE	allAlpha
molar	JJ	NP	O 125 130	[12]	[5]	LOWERCASE	allAlpha
charge	NN	NP	O 131 137	[13]	[6]	LOWERCASE	allAlpha
ratios	NNS	NP	O 138 144	[14]	[6]	LOWERCASE	allAlpha
of	IN	PP	O 145 147	[15]	[2]	LOWERCASE	allAlpha
L	NN	NP	O 148 149	[16]	[1]	CAPITALIZED	allAlpha
to	TO	OTHER	O 150 152	[17]	[2]	LOWERCASE	allAlpha
D	NN	NP	O 153 154	[18]	[1]	CAPITALIZED	allAlpha
while	IN	OTHER	O 155 160	[19]	[5]	LOWERCASE	allAlpha
the	DT	OTHER	O 161 164	[20]	[3]	LOWERCASE	allAlpha
peptide	NN	NP	O 165 172	[21]	[7]	LOWERCASE	allAlpha
P	NN	NP	O 173 174	[22]	[1]	CAPITALIZED	allAlpha
to	TO	OTHER	O 175 177	[23]	[2]	LOWERCASE	allAlpha
D	NN	NP	O 178 179	[24]	[1]	CAPITALIZED	allAlpha
molar	JJ	NP	O 180 185	[25]	[5]	LOWERCASE	allAlpha
charge	NN	NP	O 186 192	[26]	[6]	LOWERCASE	allAlpha
ratio	NN	NP	O 193 198	[27]	[5]	LOWERCASE	allAlpha
was	VBD	VP	O 199 202	[28]	[3]	LOWERCASE	allAlpha
maintained	VBN	VP	O 203 213	[29]	[10]	LOWERCASE	allAlpha
constant	JJ	OTHER	O 214 222	[30]	[8]	LOWERCASE	allAlpha
at	IN	OTHER	O 223 225	[31]	[2]	LOWERCASE	allAlpha
3:1.	CD	OTHER	O 226 229	[32]	[4]	LOWERCASE	ContainSymbol

Method	NN	NP	O 231 237	[1]	[6]	CAPITALIZED	allAlpha
1	CD	OTHER	O 238 239	[2]	[1]	LOWERCASE	ContainSymbol
(L:D:P):	NN	NP	O 240 248	[3]	[8]	LOWERCASE	ContainSymbol
DNA	NN	NP	B-KP 249 252	[4]	[3]	CAPITALIZED	allAlpha
was	VBD	VP	O 253 256	[5]	[3]	LOWERCASE	allAlpha
first	RB	OTHER	O 257 262	[6]	[5]	LOWERCASE	allAlpha
added	VBN	VP	B-KP 263 268	[7]	[5]	LOWERCASE	allAlpha
to	TO	OTHER	O 269 271	[8]	[2]	LOWERCASE	allAlpha
an	DT	OTHER	B-KP 272 274	[9]	[2]	LOWERCASE	allAlpha
anionic	JJ	OTHER	I-KP 275 282	[10]	[7]	LOWERCASE	allAlpha
liposome	FW	NP	I-KP 283 291	[11]	[8]	LOWERCASE	allAlpha
(LA,	FW	OTHER	O 292 295	[12]	[4]	LOWERCASE	ContainSymbol
LAP1	NN	NP	I-KP 297 301	[13]	[4]	CAPITALIZED	ContainSymbol
or	CC	OTHER	I-KP 302 304	[14]	[2]	LOWERCASE	allAlpha
LAP2)	NN	NP	O 305 310	[15]	[5]	CAPITALIZED	ContainSymbol
and	CC	OTHER	O 311 314	[16]	[3]	LOWERCASE	allAlpha
incubated	VBN	VP	B-KP 315 324	[17]	[9]	LOWERCASE	allAlpha
for	IN	PP	O 325 328	[18]	[3]	LOWERCASE	allAlpha
15min	NN	NP	O 329 334	[19]	[5]	LOWERCASE	ContainSymbol
at	IN	PP	O 335 337	[20]	[2]	LOWERCASE	allAlpha
room	NN	NP	O 338 342	[21]	[4]	LOWERCASE	allAlpha
temperature	NN	NP	O 343 354	[22]	[11]	LOWERCASE	allAlpha
and	CC	OTHER	O 355 358	[23]	[3]	LOWERCASE	allAlpha
then	RB	OTHER	O 359 363	[24]	[4]	LOWERCASE	allAlpha
the	DT	OTHER	O 364 367	[25]	[3]	LOWERCASE	allAlpha
peptide	NN	NP	O 368 375	[26]	[7]	LOWERCASE	allAlpha
was	VBD	VP	O 376 379	[27]	[3]	LOWERCASE	allAlpha
added	VBN	VP	B-KP 380 385	[28]	[5]	LOWERCASE	allAlpha
with	IN	OTHER	O 386 390	[29]	[4]	LOWERCASE	allAlpha
rapid	JJ	OTHER	O 391 396	[30]	[5]	LOWERCASE	allAlpha
mixing	VBG	VP	O 397 403	[31]	[6]	LOWERCASE	allAlpha
and	CC	OTHER	O 404 407	[32]	[3]	LOWERCASE	allAlpha
incubated	VBN	VP	B-KP 408 417	[33]	[9]	LOWERCASE	allAlpha
at	IN	PP	O 418 420	[34]	[2]	LOWERCASE	allAlpha
room	NN	NP	O 421 425	[35]	[4]	LOWERCASE	allAlpha
temperature	NN	NP	O 426 437	[36]	[11]	LOWERCASE	allAlpha
for	IN	PP	O 438 441	[37]	[3]	LOWERCASE	allAlpha
a	DT	OTHER	O 442 443	[38]	[1]	LOWERCASE	allAlpha
further	JJ	NP	O 444 451	[39]	[7]	LOWERCASE	allAlpha
20min;	NN	NP	O 452 458	[40]	[6]	LOWERCASE	ContainSymbol
Method	NN	NP	O 459 465	[41]	[6]	CAPITALIZED	allAlpha
2	CD	OTHER	O 466 467	[42]	[1]	LOWERCASE	ContainSymbol
(P:D:L):	NN	NP	O 468 476	[43]	[8]	LOWERCASE	ContainSymbol
the	DT	OTHER	O 477 480	[44]	[3]	LOWERCASE	allAlpha
peptide	NN	NP	B-KP 481 488	[45]	[7]	LOWERCASE	allAlpha
was	VBD	VP	O 489 492	[46]	[3]	LOWERCASE	allAlpha
added	VBN	VP	B-KP 493 498	[47]	[5]	LOWERCASE	allAlpha
to	TO	OTHER	O 499 501	[48]	[2]	LOWERCASE	allAlpha
the	DT	OTHER	O 502 505	[49]	[3]	LOWERCASE	allAlpha
DNA	NN	NP	O 506 509	[50]	[3]	CAPITALIZED	allAlpha
and	CC	OTHER	O 510 513	[51]	[3]	LOWERCASE	allAlpha
incubated	VBN	VP	B-KP 514 523	[52]	[9]	LOWERCASE	allAlpha
for	IN	PP	O 524 527	[53]	[3]	LOWERCASE	allAlpha
15min	NN	NP	O 528 533	[54]	[5]	LOWERCASE	ContainSymbol
at	IN	PP	O 534 536	[55]	[2]	LOWERCASE	allAlpha
room	NN	NP	O 537 541	[56]	[4]	LOWERCASE	allAlpha
temperature	NN	NP	O 542 553	[57]	[11]	LOWERCASE	allAlpha
and	CC	OTHER	O 554 557	[58]	[3]	LOWERCASE	allAlpha
then	RB	OTHER	O 558 562	[59]	[4]	LOWERCASE	allAlpha
liposome	NN	NP	B-KP 563 571	[60]	[8]	LOWERCASE	allAlpha
was	VBD	VP	O 572 575	[61]	[3]	LOWERCASE	allAlpha
added	VBN	VP	B-KP 576 581	[62]	[5]	LOWERCASE	allAlpha
with	IN	OTHER	O 582 586	[63]	[4]	LOWERCASE	allAlpha
rapid	JJ	OTHER	O 587 592	[64]	[5]	LOWERCASE	allAlpha
mixing	VBG	VP	O 593 599	[65]	[6]	LOWERCASE	allAlpha
and	CC	OTHER	O 600 603	[66]	[3]	LOWERCASE	allAlpha
incubated	VBN	VP	B-KP 604 613	[67]	[9]	LOWERCASE	allAlpha
at	IN	PP	O 614 616	[68]	[2]	LOWERCASE	allAlpha
room	NN	NP	O 617 621	[69]	[4]	LOWERCASE	allAlpha
temperature	NN	NP	O 622 633	[70]	[11]	LOWERCASE	allAlpha
for	IN	PP	O 634 637	[71]	[3]	LOWERCASE	allAlpha
a	DT	OTHER	O 638 639	[72]	[1]	LOWERCASE	allAlpha
further	JJ	NP	O 640 647	[73]	[7]	LOWERCASE	allAlpha
20min.	NN	NP	O 648 653	[74]	[6]	LOWERCASE	ContainSymbol

Irrespective	JJ	OTHER	O 655 667	[1]	[12]	CAPITALIZED	allAlpha
of	IN	PP	O 668 670	[2]	[2]	LOWERCASE	allAlpha
the	DT	OTHER	O 671 674	[3]	[3]	LOWERCASE	allAlpha
method	NN	NP	O 675 681	[4]	[6]	LOWERCASE	allAlpha
of	IN	PP	O 682 684	[5]	[2]	LOWERCASE	allAlpha
order	NN	NP	O 685 690	[6]	[5]	LOWERCASE	allAlpha
of	IN	PP	O 691 693	[7]	[2]	LOWERCASE	allAlpha
mixing,	NN	NP	O 694 700	[8]	[7]	LOWERCASE	ContainSymbol
all	DT	OTHER	O 702 705	[9]	[3]	LOWERCASE	allAlpha
molar	JJ	NP	O 706 711	[10]	[5]	LOWERCASE	allAlpha
charge	NN	NP	O 712 718	[11]	[6]	LOWERCASE	allAlpha
ratios	NNS	NP	O 719 725	[12]	[6]	LOWERCASE	allAlpha
in	IN	OTHER	O 726 728	[13]	[2]	LOWERCASE	allAlpha
this	DT	OTHER	O 729 733	[14]	[4]	LOWERCASE	allAlpha
study	NN	NP	O 734 739	[15]	[5]	LOWERCASE	allAlpha
refer	VBP	VP	O 740 745	[16]	[5]	LOWERCASE	allAlpha
to	TO	OTHER	O 746 748	[17]	[2]	LOWERCASE	allAlpha
L:P:D.	VB	VP	O 749 754	[18]	[6]	CAPITALIZED	ContainSymbol
Cationic	JJ	NP	O 756 764	[19]	[8]	CAPITALIZED	allAlpha
formulations	NNS	NP	O 765 777	[20]	[12]	LOWERCASE	allAlpha
LPD	NNP	NP	B-KP 778 781	[21]	[3]	CAPITALIZED	allAlpha
and	CC	OTHER	O 782 785	[22]	[3]	LOWERCASE	allAlpha
LCPRGPD	NNP	NP	B-KP 786 793	[23]	[7]	CAPITALIZED	allAlpha
were	VBD	VP	O 794 798	[24]	[4]	LOWERCASE	allAlpha
prepared	VBN	VP	O 799 807	[25]	[8]	LOWERCASE	allAlpha
in	IN	OTHER	O 808 810	[26]	[2]	LOWERCASE	allAlpha
the	DT	OTHER	O 811 814	[27]	[3]	LOWERCASE	allAlpha
order	NN	NP	O 815 820	[28]	[5]	LOWERCASE	allAlpha
L:P:D	NN	NP	O 821 826	[29]	[5]	CAPITALIZED	ContainSymbol
as	IN	OTHER	O 827 829	[30]	[2]	LOWERCASE	allAlpha
described	VBN	VP	O 830 839	[31]	[9]	LOWERCASE	allAlpha
previously;	FW	OTHER	O 840 851	[32]	[11]	LOWERCASE	ContainSymbol
first,	FW	OTHER	O 852 857	[33]	[6]	LOWERCASE	ContainSymbol
the	DT	OTHER	O 859 862	[34]	[3]	LOWERCASE	allAlpha
peptide	NN	NP	O 863 870	[35]	[7]	LOWERCASE	allAlpha
was	VBD	VP	O 871 874	[36]	[3]	LOWERCASE	allAlpha
added	VBN	VP	B-KP 875 880	[37]	[5]	LOWERCASE	allAlpha
to	TO	OTHER	O 881 883	[38]	[2]	LOWERCASE	allAlpha
the	DT	OTHER	O 884 887	[39]	[3]	LOWERCASE	allAlpha
liposome	JJ	NP	O 888 896	[40]	[8]	LOWERCASE	allAlpha
DOTMA/DOPE	NN	NP	O 897 907	[41]	[10]	CAPITALIZED	ContainSymbol
or	CC	OTHER	O 908 910	[42]	[2]	LOWERCASE	allAlpha
LCPRG	NN	NP	B-KP 911 916	[43]	[5]	CAPITALIZED	allAlpha
followed	VBN	VP	O 917 925	[44]	[8]	LOWERCASE	allAlpha
by	IN	PP	O 926 928	[45]	[2]	LOWERCASE	allAlpha
addition	NN	NP	O 929 937	[46]	[8]	LOWERCASE	allAlpha
of	IN	PP	O 938 940	[47]	[2]	LOWERCASE	allAlpha
the	DT	OTHER	O 941 944	[48]	[3]	LOWERCASE	allAlpha
DNA	NN	NP	B-KP 945 948	[49]	[3]	CAPITALIZED	allAlpha
with	IN	OTHER	O 949 953	[50]	[4]	LOWERCASE	allAlpha
rapid	JJ	OTHER	B-KP 954 959	[51]	[5]	LOWERCASE	allAlpha
mixing	VBG	VP	I-KP 960 966	[52]	[6]	LOWERCASE	allAlpha
and	CC	OTHER	I-KP 967 970	[53]	[3]	LOWERCASE	allAlpha
incubated	VBN	VP	I-KP 971 980	[54]	[9]	LOWERCASE	allAlpha
for	IN	PP	O 981 984	[55]	[3]	LOWERCASE	allAlpha
30min	NN	NP	O 985 990	[56]	[5]	LOWERCASE	ContainSymbol
at	IN	PP	O 991 993	[57]	[2]	LOWERCASE	allAlpha
room	NN	NP	O 994 998	[58]	[4]	LOWERCASE	allAlpha
temperature	NN	NP	O 999 1010	[59]	[11]	LOWERCASE	allAlpha
to	TO	OTHER	O 1011 1013	[60]	[2]	LOWERCASE	allAlpha
allow	VB	VP	O 1014 1019	[61]	[5]	LOWERCASE	allAlpha
for	IN	PP	O 1020 1023	[62]	[3]	LOWERCASE	allAlpha
complex	JJ	NP	O 1024 1031	[63]	[7]	LOWERCASE	allAlpha
formation	NN	NP	O 1032 1041	[64]	[9]	LOWERCASE	allAlpha
[30].	NN	NP	O 1042 1046	[65]	[5]	LOWERCASE	ContainSymbol

The	DT	OTHER	O 1048 1051	[1]	[3]	CAPITALIZED	allAlpha
nanocomplexes	NNS	NP	O 1052 1065	[2]	[13]	LOWERCASE	allAlpha
prepared	VBN	VP	O 1066 1074	[3]	[8]	LOWERCASE	allAlpha
were	VBD	VP	O 1075 1079	[4]	[4]	LOWERCASE	allAlpha
termed	VBN	VP	O 1080 1086	[5]	[6]	LOWERCASE	allAlpha
LPD	NNP	NP	B-KP 1087 1090	[6]	[3]	CAPITALIZED	allAlpha
(liposome	NNP	NP	O 1091 1100	[7]	[9]	LOWERCASE	ContainSymbol
DOTMA/DOPE),	NNP	NP	O 1101 1112	[8]	[12]	CAPITALIZED	ContainSymbol
LADP	NNP	NP	B-KP 1114 1118	[9]	[4]	CAPITALIZED	allAlpha
and	CC	OTHER	O 1119 1122	[10]	[3]	LOWERCASE	allAlpha
PDLA	NNP	NP	B-KP 1123 1127	[11]	[4]	CAPITALIZED	allAlpha
(liposome	FW	NP	O 1128 1137	[12]	[9]	LOWERCASE	ContainSymbol
LA),	FW	OTHER	O 1138 1141	[13]	[4]	CAPITALIZED	ContainSymbol
PDLAP1	NN	NP	B-KP 1143 1149	[14]	[6]	CAPITALIZED	ContainSymbol
(liposome	NN	NP	O 1150 1159	[15]	[9]	LOWERCASE	ContainSymbol
LAP1),	NN	NP	O 1160 1165	[16]	[6]	CAPITALIZED	ContainSymbol
PDLAP2	NN	NP	B-KP 1167 1173	[17]	[6]	CAPITALIZED	ContainSymbol
(liposome	FW	NP	O 1174 1183	[18]	[9]	LOWERCASE	ContainSymbol
LAP2),	FW	OTHER	O 1184 1189	[19]	[6]	CAPITALIZED	ContainSymbol
PDLAPRG	FW	OTHER	B-KP 1191 1198	[20]	[7]	CAPITALIZED	allAlpha
(liposome	FW	NP	O 1199 1208	[21]	[9]	LOWERCASE	ContainSymbol
LAPRG)	NN	NP	O 1209 1215	[22]	[6]	CAPITALIZED	ContainSymbol
and	CC	OTHER	O 1216 1219	[23]	[3]	LOWERCASE	allAlpha
LCPRGPD	NN	NP	B-KP 1220 1227	[24]	[7]	CAPITALIZED	allAlpha
(liposome	FW	NP	O 1228 1237	[25]	[9]	LOWERCASE	ContainSymbol
LCPRG).	FW	OTHER	O 1238 1244	[26]	[7]	CAPITALIZED	ContainSymbol

